N. Sai kiran, et al. “Method Development and Its Validation for Antineoplastic Agents (Ruxolitinib) by RP-HPLC”. International Journal of Allied Medical Sciences and Clinical Research, vol. 10, no. 2, July 2022, pp. 268-73, doi:10.61096/ijamscr.v10.iss2.2022.268-273.